Galectin Therapeutics(GALT)
NORCROSS, GA
BiotechnologyFocus: Small Molecules
Galectin Therapeutics is a life sciences company focused on Small Molecules.
OncologyInfectious DiseasesCardiovascularGastroenterologyImmunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
1 mg/kg GR-MD-02
Metastatic MelanomaClinical Trials (1)
NCT02117362Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma
Phase 1GM-CT-01
Colorectal CancerClinical Trials (1)
NCT00054977Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
Phase 1GR-MD-02
MelanomaClinical Trials (1)
NCT02575404GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients
Phase 1Phase 1
Clinical Trials (1)
NCT01899859Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Phase 1belapectin
Hepatic ImpairmentClinical Trials (1)
NCT04332432A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
Phase 1GM-CT-01 plus 5-Fluorouracil
Colorectal CancerClinical Trials (1)
NCT00110721GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
Phase 2GR-MD-02
PsoriasisClinical Trials (1)
NCT02407041An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis
Phase 2GM-CT-01
Cancer of the Bile DuctClinical Trials (1)
NCT00386516Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
Phase 2GR-MD-02
Hypertension, PortalClinical Trials (1)
NCT02462967Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Phase 2GM-CT-01
Colorectal CancerClinical Trials (1)
NCT00388700A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Phase 2GR-MD-02
Nonalcoholic SteatohepatitisClinical Trials (1)
NCT02421094Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
Phase 2belapectin
Prevention of Esophageal VaricesClinical Trials (1)
NCT04365868Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 12 clinical trials
SEC Filings: 2 available